Question of the Day

Question of the Day – Wednesday September 18, 2019

Question – In order to “provide Americans, including the most sensitive populations, with a margin of protection from a life-time of exposure to PFOA and PFOS from drinking water, EPA established the health advisory levels” for these chemicals. What is the current EPA health advisory level for these chemicals in drinking water?

 

 

View full post for answer.

Question of the Day – Friday September 13, 2019

Question – The article cited below notes “Neural-tube defects occur by the end of the sixth week of pregnancy (i.e. the fourth week after fertilization) and have been associated with exposure to specific drugs in pregnancy.” What newer antiretroviral agent (ARTs) has been posited to be associated with the development of neural-tube defects when used at the time of conception?

 

 

View full post for answer.

Question of the Day – Thursday September 12, 2019

Question – The article cited below notes “Immune thrombocytopenia (ITP) is an autoimmune disease characterized by isolated thrombocytopenia. Patients may be asymptomatic at presentation or they may present with mild mucocutaneous to life threatening bleeding”. Sudden onset of ITP has been reported after initiation of which medications?

 

 

View full post for answer.